Currently predicting for Wed, 1 May 2024

Trading levels for ESPR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.08 5.41 %
R2 2.04 3.57 %
R1 2.02 2.43 %
Current price: 1.97
Support S1 1.95 -1.25 %
S2 1.92 -2.39 %
S3 1.89 -4.23 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.19 11.17 %
R2 2.14 8.63 %
R1 2.07 5.08 %
Current price 1.97
Support S1 1.95 -1.02%
S2 1.94 -1.78%
S3 1.91 -3.05%

ESPR Predictions History

8 months ago
PredictionBot.Warren predicted that ESPR for 2023-08-04 is going $1.60 (-1.65%)

8 months ago
AlaFolia predicted that ESPR for 2023-08-04 is going

Rank:

2 years ago
JS predicted that ESPR for 2022-03-11 is going $4.77 (0.63%)

2 years ago
tabithawasserman.299615 predicted that ESPR for 2022-03-11 is going

2 years ago
tabithawasserman.299615 predicted that ESPR for 2022-03-10 is going

2 years ago
JS predicted that ESPR for 2022-01-18 is going $3.80 (-3.31%)

2 years ago
Yury.Sushkevich.103615 predicted that ESPR for 2022-01-18 is going

Rank:

2 years ago
JS predicted that ESPR for 2021-05-24 is going $21.33 (5.23%)

2 years ago
Castorela predicted that ESPR for 2021-05-24 is going

Rank:

2 years ago
JS predicted that ESPR for 2021-05-13 is going $23.96 (6.96%)

Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT